YOLT-202 is currently under investigation in a trial assessing tolerability YolTech Therapeutics has received clearance from the US Food and Drug Administration (FDA) to begin a Phase II/III clinical ...
The FDA announced a new approved use for the drug leucovorin, which Trump has touted as a treatment for autism. But the ...
Novartis has received the US Food and Drug Administration (FDA) approval for Cosentyx (secukinumab) to treat paediatric patients aged 12 years and above with moderate to severe hidradenitis ...
Dr. Marty Makary, the FDA’s commissioner, said in a statement that the “approval represents a significant milestone for ...
The FDA approved secukimumab for children aged 12 years and older with moderate to severe hidradenitis suppurativa, Novartis announced in a press release.The approval makes secukinumab (Cosentyx) the ...
Real talk. We don’t talk enough about sexually transmitted infections and diseases. Most are very treatable, however. The FDA ...
WASHINGTON — Sen. Josh Hawley rolled out long-shot legislation this week to override the Food and Drug Administration’s ...
Sen. Josh Hawley, R-Mo., introduced a bill to ban the abortion pill mifepristone, calling it "inherently dangerous" and ...
Republican lawmakers are focused on limiting the availability of abortion medication, the most common way to terminate early pregnancies in the United States. The proposal comes as several states ...
The move comes months after the Trump administration touted leucovorin as a potential therapy for a broader group of patients with autism symptoms.
The Food and Drug Administration has approved expanded use of leucovorin calcium tablets for treating cerebral folate ...
By Ahmed Aboulenein and Julie Steenhuysen WASHINGTON, March 10 (Reuters) - The U.S. FDA approved leucovorin, a decades-old ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results